Medicus Sciences Acquisition Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MSAC research report →
Companywww.medicusspac.com
Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
- CEO
- Jacob Jay Gottlieb
- IPO
- 2021
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- 55.33
- P/S
- 0.00
- P/B
- 1.23
- EV/EBITDA
- 0.46
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 4.45%
- ROIC
- -0.66%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $1.90M · 0.00%
- EPS
- $0.18 · 0.00%
- Op Income
- $-615,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $10.18
- 52W Low
- $9.72
- 50D MA
- $10.10
- 200D MA
- $9.93
- Beta
- 0.00
- Avg Volume
- 51.85K
Get TickerSpark's AI analysis on MSAC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MSAC Coverage
We haven't published any research on MSAC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MSAC Report →